Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-12

Clinical Trial Update: Cost-effectiveness Study of Beclomethasone Versus Ciclesonide as Controller Medications in Pediatric Asthma [Phase 4]

View source ↗

Summary

Phase 4 cost-effectiveness study comparing Beclomethasone with Ciclesonide as controller therapies in pediatric asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Beclomethasone (beclomethasone)
  • ciclesonide (ciclesonide)

Snippet

Sponsor: Grünenthal Colombiana S.A. | Conditions: Asthma | Phase 4 | Status: COMPLETED